154 related articles for article (PubMed ID: 9625172)
1. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations.
Schorge JO; Muto MG; Welch WR; Bandera CA; Rubin SC; Bell DA; Berkowitz RS; Mok SC
J Natl Cancer Inst; 1998 Jun; 90(11):841-5. PubMed ID: 9625172
[TBL] [Abstract][Full Text] [Related]
2. Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum.
Huang LW; Garrett AP; Schorge JO; Muto MG; Bell DA; Welch WR; Berkowitz RS; Mok SC
Am J Clin Pathol; 2000 Jul; 114(1):93-9. PubMed ID: 10884804
[TBL] [Abstract][Full Text] [Related]
3. Primary peritoneal carcinoma can have multifocal origins: implications for prophylactic oophorectomy.
Eisen A; Weber BL
J Natl Cancer Inst; 1998 Jun; 90(11):797-9. PubMed ID: 9625162
[No Abstract] [Full Text] [Related]
4. Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum.
Bandera CA; Muto MG; Welch WR; Berkowitz RS; Mok SC
Oncogene; 1998 Jul; 16(26):3455-9. PubMed ID: 9692553
[TBL] [Abstract][Full Text] [Related]
5. BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis.
Schorge JO; Muto MG; Lee SJ; Huang LW; Welch WR; Bell DA; Keung EZ; Berkowitz RS; Mok SC
Cancer Res; 2000 Mar; 60(5):1361-4. PubMed ID: 10728699
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum.
Schorge JO; Miller YB; Qi LJ; Muto MG; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Mar; 76(3):369-72. PubMed ID: 10684712
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum.
Huang LW; Garrett AP; Muto MG; Colitti CV; Bell DA; Welch WR; Berkowitz RS; Mok SC
Hum Pathol; 2000 Mar; 31(3):367-73. PubMed ID: 10746681
[TBL] [Abstract][Full Text] [Related]
8. Is papillary serous carcinoma of the peritoneum (PSCP) a multifocal disease?
Imura J; Fujimori T
J Gastroenterol; 2000; 35(7):570-2. PubMed ID: 10905369
[No Abstract] [Full Text] [Related]
9. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.
Casey MJ; Bewtra C
Fam Cancer; 2004; 3(3-4):265-81. PubMed ID: 15516851
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum.
Muto MG; Welch WR; Mok SC; Bandera CA; Fishbaugh PM; Tsao SW; Lau CC; Goodman HM; Knapp RC; Berkowitz RS
Cancer Res; 1995 Feb; 55(3):490-2. PubMed ID: 7834614
[TBL] [Abstract][Full Text] [Related]
11. Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinoma.
Altaras MM; Bernheim J; Zehavi T; Drucker L; Uziel O; Fishman A
Gynecol Oncol; 2002 Feb; 84(2):245-51. PubMed ID: 11812082
[TBL] [Abstract][Full Text] [Related]
12. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum.
Garrett AP; Ng SW; Muto MG; Welch WR; Bell DA; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Apr; 77(1):105-11. PubMed ID: 10739698
[TBL] [Abstract][Full Text] [Related]
13. Papillary serous carcinoma of the peritoneum: analysis of clonality of peritoneal tumors.
Nishimura- M; Wakabayashi M; Hashimoto T; Shibata J; Ueyama H; Ebina M; Fujiyama Y; Bamba T
J Gastroenterol; 2000; 35(7):540-7. PubMed ID: 10905363
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum.
Bandera CA; Muto MG; Schorge JO; Berkowitz RS; Rubin SC; Mok SC
Obstet Gynecol; 1998 Oct; 92(4 Pt 1):596-600. PubMed ID: 9764635
[TBL] [Abstract][Full Text] [Related]
15. Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.
Buller RE; Sood AK; Lallas T; Buekers T; Skilling JS
J Natl Cancer Inst; 1999 Feb; 91(4):339-46. PubMed ID: 10050867
[TBL] [Abstract][Full Text] [Related]
16. Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma.
Quezado MM; Moskaluk CA; Bryant B; Mills SE; Merino MJ
Hum Pathol; 1999 Feb; 30(2):203-7. PubMed ID: 10029450
[TBL] [Abstract][Full Text] [Related]
17. Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.
Hornreich G; Beller U; Lavie O; Renbaum P; Cohen Y; Levy-Lahad E
Gynecol Oncol; 1999 Nov; 75(2):300-4. PubMed ID: 10525392
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
Lu KH; Bell DA; Welch WR; Berkowitz RS; Mok SC
Cancer Res; 1998 Jun; 58(11):2328-30. PubMed ID: 9622067
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 germline mutations in women with uterine serous papillary carcinoma.
Lavie O; Hornreich G; Ben Arie A; Renbaum P; Levy-Lahad E; Beller U
Obstet Gynecol; 2000 Jul; 96(1):28-32. PubMed ID: 10862837
[TBL] [Abstract][Full Text] [Related]
20. A diagnostic dilemma following risk-reducing surgery for BRCA1 mutation - a case report of primary papillary serous carcinoma presenting as sigmoid cancer.
Chand M; Moore PJ; Clarke AD; Nash GF; Hickisk T
World J Surg Oncol; 2007 Sep; 5():102. PubMed ID: 17850658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]